Abstract:Aims/Purpose: Hypoxia is a vital cause of neurodegenerative diseases such as glaucoma and retinal ischemia. We investigated the potential neuroprotective effects of anti‐cytokine antibodies against hypoxic damage. Methods: An in vitro hypoxia model was established using cobalt chloride (CoCl 2 ) stimulation in microglial cells (BV‐2). Immunofluorescence staining was performed to detect the expression markers of different microglial phenotypes in BV‐2. Different concentrations of CoCl 2 (0–150 μM) were tested to generate dose–response curves. Following exposure to CoCl 2 at an approximate IC 50 of 0.1 mM, BV‐2 were treated with anti‐tumour necrosis factor‐alpha (anti‐TNF‐α) or anti‐ interleukin‐1 beta (anti‐IL‐1β) antibodies for 24 h. Cell viability was determined by MTS assay. Proteome changes in BV‐2 were analysed with the mass spectrometry‐based proteomics approach. Results: Immunocytochemistry revealed the expression of M1 marker consisting CD68 and M2 marker CD206 in the BV‐2 cells. Hypoxia induced by mimetic CoCl 2 led to a concentration‐dependent viability impairment in BV‐2 and cells treated with 0.1 mM CoCl 2 for 24 h showed decreased viability of ~46%‐ 50%. Interestingly, the application of anti‐TNF‐α (2ug/ml) and anti‐IL‐1β (4ug/ml) antibodies significantly improved the BV‐2 cell viability to 80% ( p < 0.0001) and 76% ( p < 0.0001), respectively. Proteomics and bioinformatics analyses of the differentially expressed proteins revealed that CoCl 2 induced proteome alterations involved in mitochondrial dysfunction signalling pathway ( p = 1.10 × 10 −3 ), which were eliminated by the treatment with both anti‐TNF‐α and anti‐IL‐1β. Besides, CoCl 2 ‐induced activation of endoplasmic reticulum (ER) stress response ( p = 3.33 × 10 −9 ) was alleviated by anti‐IL‐1β and anti‐TNF‐α treatment ( p = 1.7 × 10 −7 and p = 8.82 × 10 −7 , respectively). Particularly, anti‐TNF‐α antibody significantly downregulated proteins involved in apoptosis ( p = 1.58 × 10 −10 ). Anti‐IL‐1β induced Nrf2‐mediated antioxidant response and exerts protection against oxidative stress ( p = 1.00 × 10 −6 ). Conclusions: Antibodies targeting cytokines provide neuroprotective effects on microglial cells from hypoxic stress. These findings demonstrated the potential use of anti‐cytokines in the treatment of neurodegenerative diseases.

Signal transducer and activator of transcription-3 mediated neuroprotective effect of interleukin-6 on cobalt chloride mimetic hypoxic cell death in R28 cells

Overexpression of MiR-188-5p Downregulates IL6ST/STAT3/ NLRP3 Pathway to Ameliorate Neuron Injury in Oxygen-glucose Deprivation/Reoxygenation

Regulatory T Cell is Critical for Interleukin-33-mediated Neuroprotection Against Stroke.

Increased Retinal Ganglion Cell Survival by Exogenous IL-2 Depends on IL-10, Dopamine D1 Receptors, and Classical IL-2/IL-2R Signaling Pathways

Anti‐cytokine antibodies attenuated neuroglial degeneration under hypoxic stress

Suppressors of cytokine signaling 3 inhibits cell viability of retinal ganglion cells after optic nerve injury

Microglia-induced Autophagic Death of Neurons Via IL-6/STAT3/miR-30d Signaling Following Hypoxia/ischemia.

N-Acetylcysteine Protects Against Hypoxia Mimetic-Induced Autophagy by Targeting the HIF-1α Pathway in Retinal Ganglion Cells

Therapeutic Retrobulbar Inhibition of STAT3 Protects Ischemic Retina Ganglion Cells

Interleukin 3 Inhibits Glutamate-Cytotoxicity in Neuroblastoma Cell Line

Blockade of interleukin-6 trans-signaling prevents mitochondrial dysfunction and cellular senescence in retinal endothelial cells

Neuroprotective effect of astrocyte-derived IL-33 in neonatal hypoxic-ischemic brain injury

IL-10 Protects Neurites in Oxygen-Glucose-Deprived Cortical Neurons Through the PI3K/Akt Pathway

CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway

Protective effects of blocking PD-1 pathway on retinal ganglion cells in a mouse model of chronic ocular hypertension

IL-6/STAT3 Induced Neuron Apoptosis in Hypoxia by Downregulating ATF6 Expression

Tat-Mediated Delivery of Neuroglobin Attenuates Apoptosis Induced by Oxygen-Glucose Deprivation Via the Jak2/Stat3 Pathway in Vitro

IL-33 protects retinal structure and function via mTOR/S6 signaling pathway in optic nerve crush

MicroRNA-203a-3p Regulates CoCl2-induced Apoptosis in Human Retinal Pigment Epithelial Cells by Targeting Suppressor of Cytokine Signaling 3

STAT3 Activation Protects Retinal Ganglion Cell Layer Neurons in Response to Stress

Neuroprotective and Anti-Inflammatory Activities of Hybrid Small-Molecule SA-10 in Ischemia/Reperfusion-Induced Retinal Neuronal Injury Models